Lincoln Pharmaceuticals launches cough syrup ‘NAMCOLD-DX’

13 Aug 2015 Evaluate

Lincoln Pharmaceuticals has successfully launched a cough syrup ‘NAMCOLD-DX’, which contains Dextromethorphan Polistirex. This is an Extended Release, unique product of Novel Technology. ‘NAMCOLD-DX’ is designed for all age group of patient above 4 years. The product is time tested and many trials have been done and it is approved by Drug Controller General of India (DCGI).

Normal cough syrups are effective up to 3-4 hours, so in 24 hours the patient has to take the syrup 4 to 5 times. But, this innovative product ‘NAMCOLD-DX’ is extended release, so the drug releases periodically and therefore the patient has to take only 2 doses during 24 hours.

Lincoln Pharmaceuticals is a company is based at Ahmedabad and engaged in Manufacturing and Export of Pharmaceuticals formulations under various Therapeutic product group, plant duly complied with WHO-GMP guidelines. The Company is exporting more than 45 countries along with Domestic market in more than 20 states in India.


Lincoln Pharma Share Price

483.20 5.65 (1.18%)
31-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.75
Dr. Reddys Lab 1271.05
Cipla 1510.90
Zydus Lifesciences 914.65
Lupin 2112.00
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×